MoneyWorks4Me

Zim Laboratories - Quaterly Results

21 May 2022 Evaluate
The sales moved up 42.27% to Rs. 1041.08 millions for the March 2022 quarter as compared to Rs. 731.75 millions during the year-ago period.The company almost doubled its revenue to Rs. 64.40 millions  from Rs. 13.83 millions in the quarter ended March 2022.Operating Profit saw a handsome growth to 153.27 millions from 93.76 millions in the quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1041.08 731.75 42.27 3294.94 3036.29 8.52 3294.94 3036.29 8.52
Other Income 16.47 8.49 93.99 45.06 24.49 83.99 45.06 24.49 83.99
PBIDT 153.27 93.76 63.47 424.40 392.62 8.09 424.40 392.62 8.09
Interest 14.31 29.32 -51.19 83.06 108.86 -23.70 83.06 108.86 -23.70
PBDT 138.96 64.44 115.64 341.34 231.95 47.16 341.34 231.95 47.16
Depreciation 38.77 38.94 -0.44 148.37 146.14 1.53 148.37 146.14 1.53
PBT 100.19 25.50 292.90 192.97 85.81 124.88 192.97 85.81 124.88
TAX 35.79 11.67 206.68 62.84 29.64 112.01 62.84 29.64 112.01
Deferred Tax 16.60 33.07 -49.80 28.84 29.47 -2.14 28.84 29.47 -2.14
PAT 64.40 13.83 365.65 130.13 56.17 131.67 130.13 56.17 131.67
Equity 162.42 162.42 0.00 162.42 162.42 0.00 162.42 162.42 0.00
PBIDTM(%) 14.72 12.81 14.90 12.88 12.93 -0.39 12.88 12.93 -0.39
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..